Dolby Laboratories

Company Profile

Dolby Laboratories had its IPO on 2005-02-17 under the ticker symbol DLB.

The company operates in the Industrials sector and Specialty Business Services industry. Dolby Laboratories has a staff strength of 2,336 employees.

Stock update

Shares of Dolby Laboratories opened at $82.77 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $81.74 - $83.71, and closed at $82.02.

This is a -1.73% slip from the previous day's closing price.

A total volume of 498,488 shares were traded at the close of the day’s session.

In the last one week, shares of Dolby Laboratories have slipped by -3.54%.

Dolby Laboratories's Key Ratios

Dolby Laboratories has a market cap of $7.90 billion, indicating a price to book ratio of 3.1258 and a price to sales ratio of 5.4393.

In the last 12-months Dolby Laboratories’s revenue was $1.28 billion with a gross profit of $1.11 billion and an EBITDA of $364.35 million. The EBITDA ratio measures Dolby Laboratories's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Dolby Laboratories’s operating margin was 22% while its return on assets stood at 5.96% with a return of equity of 9.78%.

In Q1, Dolby Laboratories’s quarterly earnings growth was a positive 172.2% while revenue growth was a positive 12.4%.

Dolby Laboratories’s PE and PEG Ratio

Forward PE

20.5339

Trailing PE

32.6996

PEG

2.0755

Its diluted EPS in the last 12-months stands at $2.53 per share while it has a forward price to earnings multiple of 20.5339 and a PEG multiple of 2.0755. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Dolby Laboratories’s profitability.

Dolby Laboratories stock is trading at a EV to sales ratio of 4.9951 and a EV to EBITDA ratio of 19.6153. Its price to sales ratio in the trailing 12-months stood at 5.4393.

Dolby Laboratories stock pays annual dividends of $1.06 per share, indicating a yield of 1.32% and a payout ratio of 29.53%.

Balance sheet and cash flow metrics

Total Assets

$2.84 billion

Total Liabilities

$314.01 million

Operating Cash Flow

$23.59 million

Capital Expenditure

$7.52 million

Dividend Payout Ratio

29.53%

Dolby Laboratories ended 2024 with $2.84 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $2.84 billion while shareholder equity stood at $2.35 billion.

Dolby Laboratories ended 2024 with $0 in deferred long-term liabilities, $314.01 million in other current liabilities, 95000.00 in common stock, $2.38 billion in retained earnings and $370.13 million in goodwill. Its cash balance stood at $688.44 million and cash and short-term investments were $814.84 million. The company’s total short-term debt was $12,625,000 while long-term debt stood at $0.

Dolby Laboratories’s total current assets stands at $1.46 billion while long-term investments were $100.80 million and short-term investments were $126.39 million. Its net receivables were $558.58 million compared to accounts payable of $17.17 million and inventory worth $30.35 million.

In 2024, Dolby Laboratories's operating cash flow was $23.59 million while its capital expenditure stood at $7.52 million.

Comparatively, Dolby Laboratories paid $0.30 in dividends in 2024.

Other key metrics

Current Trading Price

$82.02

52-Week High

$87.4943

52-Week Low

$60.9243

Analyst Target Price

$93

Dolby Laboratories stock is currently trading at $82.02 per share. It touched a 52-week high of $87.4943 and a 52-week low of $87.4943. Analysts tracking the stock have a 12-month average target price of $93.

Its 50-day moving average was $84.46 and 200-day moving average was $80.96 The short ratio stood at 2.6 indicating a short percent outstanding of 0%.

Around 160.6% of the company’s stock are held by insiders while 9521.7% are held by institutions.